GINKGO PHARMA CO LTD has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ALMAC DISCOVERY LTD, CHANDRAN V RAVI and ALLGENESIS BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Australia | 1 | |
#8 | Israel | 1 | |
#9 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chen Li | 17 |
#2 | Li Ben | 9 |
#3 | Zhai Peibin | 9 |
#4 | Li Xiaowen | 8 |
#5 | Shao Qing | 8 |
#6 | Jiang Tao | 7 |
#7 | Wu Jin | 6 |
#8 | Zhai Peibing | 6 |
#9 | Xue Xiaojian | 3 |
#10 | Shi Jian | 1 |
Publication | Filing date | Title |
---|---|---|
CN110637016A | Pyridone derivative, composition thereof and application of pyridone derivative as anti-influenza virus medicament | |
WO2018019297A1 | Isoquinolinone compound and use thereof in preparation of antiviral drugs | |
US2019381014A1 | Isoquinolinone compounds and use thereof in preparation of antiviral drugs | |
CN106132972A | For treating the novel amino phosphate ester of HCV infection | |
AU2012370125A1 | Macrocyclic compounds for suppressing replication of hepatitis C virus | |
CN103059042A | Thiophene derivative and application thereof to medicine |